The largest database of trusted experimental protocols

31 protocols using paclitaxel

1

Ovarian Cancer Cell Line Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human ovarian cancer cell line SKOV3 and Paclitaxel-resistant ovarian cancer lines SKOV3-TR and HeyA8-MDR were used. SKOV3, SKOV3-TR, and HeyA8-MDR cells were generously supplied by Professor A.K. Sood (University of Texas MD Anderson Cancer Center, Houston, TX, USA). These cells were cultured in Roswell Park Memorial Institute’s (RPMI) 1640 medium (Biowest, Nuaillé, France) supplemented with 10% (v/v) fetal bovine serum (Corning, NY, USA) and 1% penicillin/streptomycin (Thermo Fisher Scientific, Waltham, MA, USA) at 5% CO2 and 37 °C. Paclitaxel-resistant cells were cultured with 50 nM of Paclitaxel (Cayman Chemical Company, Ann Arbor, MI, USA). N-acetylcysteine (NAC) (Sigma-Aldrich, St. Louis, MO, USA) was used to free radical scavengers. Dacomitinib was purchased from MedChem Express (Monmouth Junction, NJ, USA). Dulbecco’s Phosphate-Buffered Saline (DPBS, WelGENE, Seoul, Republic of Korea) and dimethyl sulfoxide (DMSO, Sigma-Aldrich, Darmstadt, Germany) were used in this experiment.
+ Open protocol
+ Expand
2

Cell Culture and Compound Treatment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
A549 cells were cultured in RPMI 1640 and Panc 1 cells were cultured in DMEM, supplemented with 10% (v/v) FBS and 1% (v/v) antibiotic-antimycotic solution (Thermo Fisher Scientific, Waltham, MA, USA) at 37 °C in a humidified incubator containing 5% CO2. MPT0L145 was synthesized by Dr. Jing-ping Liou according to previous publications [17 (link)] and is covered by PCT/US2016/043203 filed on 20 July 2016. Gefitinib, gemcitabine and paclitaxel were purchased from Cayman Chemical (Ann Arbor, MI, USA). 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was obtained from Sigma Chemical Corp (St. Louis, MO, USA). Antibodies against various proteins were obtained from the following sources: caspase-3, LC3B from Novus biologicals (Littleton, CO, USA); β-catenin, EGFR, PARP, pAKT, AKT, pErk and Erk from Cell Signaling Technology (Danvers, MA, USA) and PIK3C3 and GAPDH from Genetex (Irvine, CA, USA).
+ Open protocol
+ Expand
3

In Vitro Enzymatic Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sepin-1 (2,2-dimethyl-5-nitro-2H-benzimidazole-1,3-dioxide) with >97% purity was purchased from ChemBridge (San Diego, CA, United States). Phenacetin, efavirenz, paclitaxel, (S)-mephenytoin, quercetin, α-naphthoflavone, ticlopidine, ketoconazole, sulfaphenazole, and dextromethorphan were purchased from Cayman Chemical (Ann Arbor, MI, United States). Reduced GSH, diclofenac sodium, quinidine, midazolam solution, formic acid, and NADPH were obtained from Sigma-Aldrich (St. Louis, MO, United States). HLM, MLM, and RLM, and the recombinant human CYP450s (EasyCYP Bactosomes) were purchased from XenoTech (Lenexa, KS, United States). All the solvents for LC and MS were of the highest grade commercially available.
+ Open protocol
+ Expand
4

Paclitaxel Cytotoxicity Evaluation in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chemotherapeutic sensitivity was measured using an MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. Cells were plated at 3 × 104 cells per well in 96-well plates and incubated with 1, 10, or 50 nM paclitaxel (Cayman Chemical) for 24 or 48 h. Following treatment, 10 μl of 12 mM MTT was added to each well and cells were placed back in the incubator at 37 °C for 4 h. The formazan was solubilized by adding 100 ul solubilization solution (40% DMSO, 16% SDS, 2% acetic acid) followed by another incubation at 37 °C for 1 h. Spectrometric absorbance at 570 nm was measured with a microplate reader. Each assay included four technical replicates and was repeated at least three times. paclitaxel effects at each dose, and differences in paclitaxel response between cell lines were analyzed using a two factor mixed design ANOVA using SPSS version 19 software (Chicago, IL). A Bonferroni test was used to adjust for multiple pairwise comparisons. Mean differences were considered statistically significant at p < 0.05.
+ Open protocol
+ Expand
5

DIAPH3-Mediated Cytoskeletal Dynamics

Check if the same lab product or an alternative is used in the 5 most similar protocols
Parental and DIAPH3-silenced or over-expressing cell lines, such as DU145, Human Mammary Epithelial (HMEC), or U87, have been described5 (link). Paclitaxel (Cayman Chemicals, Sigma), epothilone B (Cayman Chemicals), and docetaxel (LC Laboratories). Cholera toxin B (CTxB, Sigma, Life Technologies). β-octylglucopyranoside and cacodylate buffer (Sigma), Protein A/G Agarose (Santa Cruz Biotechnology), and Oregon Green-488 Paclitaxel (Invitrogen). Antibodies: Ac-tubulin (Abcam, Cell Signaling), GFP (Genscript), Cleaved PARP, E-cadherin, β-catenin, (Cell Signaling), α-tubulin (Cell Signaling, Genscript), β-tubulin and tubulin βIII (Genscript), DIAPH3 (HNH3.1, a generous gift of Dr. Henry Higgs, Dartmouth Medical School).
+ Open protocol
+ Expand
6

Synergistic Effects of Drug Combinations

Check if the same lab product or an alternative is used in the 5 most similar protocols
U251 and U87 cells were seeded in 24-well plates at 12,000 cells per well and 25,000 cells per well, respectively. At 18 hours after plating, cells were treated with BPD (Sigma), paclitaxel (AdooQ), cisplatin (Cayman), or their combinations at different concentrations for 72 hours. The sample preparation and experimental procedures (≤ 2 hours) were performed in a dark room, with a dim light source 10 feet away. Cells-containing well plates were wrapped with aluminum foil and place in incubator for 72 hours. DMSO was kept below 0.1% v/v in the culture medium. Cytotoxicity was determined using MTT assay following vendor’s protocol. The combination index (CI) was calculated using Chou-Talalay method (52 (link)), CI =aA+bB , where A is the IC50 of Drug A alone; B is the IC50 of Drug B alone, a is the IC50 of Drug A when Drugs A and B are combined; b is the IC50 of Drug B when Drugs A and B are combined. The CI Value quantitatively defines synergism (CI < 1), additive effect (CI = 1) and antagonism (CI > 1).
+ Open protocol
+ Expand
7

Synthesis and Characterization of Gold Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols
HAuCl4 (Alfa Aesar, Ward Hill, MA, USA), trisodium citrate (Fisher Scientific, Waltham, MA, USA), 1-Hexadecanethiol (TL) (Sigma Aldrich), 100% Ethanol (Decon Labs, King of Prussia, PA, USA), Chloroform (Sigma Aldrich), L-Phosphatidylcholine (PC) (Sigma Aldrich), High Density Lipoprotein (HDL) (Lee Biosolutions, St. Louis, MO, USA), Phosphate-Buffered Saline (PBS) (Life Technologies, Grand Island, NY), Cisplatin (Sigma Aldrich), Paclitaxel (Cayman Chemical, Ann Arbor, MI, USA), Acetonitrile (Sigma Aldrich), Trifluoroacetic acid (TFA) (Sigma Aldrich)
+ Open protocol
+ Expand
8

SRB Colorimetric Assay for Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
In the SRB colorimetric assay, 3000 cells/well were seeded in a 96-well plate. Cells were cultured overnight and incubated or treated with drugs for the indicated times. At the indicated time, 10% trichloroacetic acid (TCA, Sigma-Aldrich, St. Louis, MO, USA) was used to fix the cells at 4 °C for 1 h. Then, the cells were washed with distilled water and air dried. Subsequently, cells were stained with 0.057% SRB (Sigma-Aldrich, St. Louis, MO, USA) at room temperature for 30 min and washed with 1% acetic acid (J.T. Baker, Center Valley, PA, USA). Finally, 10 mM Tris Base (J.T. Baker, Center Valley, PA, USA) was used to dissolve the SRB, and the absorbance value at a wavelength of 510 nm was determined using an ELISA reader. Cisplatin and 5-fluorouracil were obtained from Sigma-Aldrich (St. Louis, MO, USA). Doxorubicin and paclitaxel were obtained from Cayman chemical (Ann Arbor, MI, USA).
+ Open protocol
+ Expand
9

Immortalized Muscle Cell Lines for Microtubule Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immortalized human muscle cell (7304.1) shPAB and control stable cell lines were generated as previously described12 (link). In brief, PABPN1 knockdown (shPAB) was generated after lentivirus transduction with a shRNA to PABPN1. The control cell line was transduced with scrambled shRNA12 (link). Myoblast cells were maintained in growth medium (F10 medium supplemented with 15% FCS, 1 ng/ml bFGF, 10 ng/ml EGF and 0.4 ug/ml Dexamethasone). Differentiation (cell fusion) was conducted in DMEM supplemented with 2% horse-serum for four days. Stable actin-eGFP overexpressing cells were generated with a lentivirus transduction in control or shPAB cell cultures. The actin-eGFP was subcloned into a lentivirus expression cassette. Actin-eGFP expression was driven by the CMV promoter. All cultures were mycoplasma-free. Microtubule destabilization or stabilization treatments were performed using nocodazole (250 nM, Cayman Chemical) or paclitaxel (25 nM, Cayman Chemical), respectively for 2 h.
+ Open protocol
+ Expand
10

Anticancer Potential of H. coubaril Extracts

Check if the same lab product or an alternative is used in the 5 most similar protocols
The H. coubaril plant was collected in the metropolitan area of Bucaramanga, Santander, Colombia (7.11° N, 73.11° W), after an ornamental pruning. A specimen was collected and identified at the herbarium of Pontificia Universidad Javeriana and classified with voucher number: HPUJ-30302. Six-hundred and twenty grams of the leaves of the plant were subjected to Soxhlet extraction with hexane (three days), followed by dichloromethane (three days) and then ethanol (eight days), thereby obtaining three extracts with different polarities [38 ]. Stock solutions of the extracts, fractions, and the isolated compound caryophyllene oxide (OXC) were prepared at a concentration of 10 mg/mL, and of the positive control Paclitaxel (Cayman Chemical, Ann Arbor, MI, USA) at a concentration of 10 μg/mL in dimethylsulfoxide (DMSO) (Sigma-Aldrich, St. Louis, MO, USA). These stock solutions were used for all tests. Cultured cells were maintained as follows: prostate adenocarcinoma (PC-3) (ATCC®, Manassas, VA, USA, CRL1435™) and lung fibroblasts (MRC-5) (ATCC®, Manassas, VA, USA, CCL-171™) in supplemented EMEM (Lonza, CH, Walkersville, MD, USA) medium with 10% (v/v) Fetal Bovine Serum (Biowest, Riverside, MO, USA), 2 mM L-glutamine, and 5000 IU/mL penicillin and 5 mg/mL streptomycin (Lonza, CH, Walkersville, MD, USA). Incubation was performed at 37 °C and 5% CO2.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!